Today: January 20, 2019, 9:50 pm
  
Business

Bicycle Therapeutics to Present at Jefferies 2018 London Healthcare Conference

PR-Inside.com: 2018-11-08 09:03:07

Bicycle Therapeutics to Present at Jefferies 2018 London Healthcare Conference

Media:
Ten Bridge Communications (U.S.)
Sarah Sutton, +1-857-242-1619
Sarah@tenbridgecommunications.com
or
Investors:
Argot Partners
Maeve Conneighton, +1-212-600-1902
maeve@argotpartners.com

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, announced today that management will present a company update at the Jefferies 2018 London Healthcare Conference. The presentation will take place at 5:20 p.m. GMT on Thursday, November 15, 2018.

About Bicycle Therapeutics
Bicycle Therapeutics is developing a unique class of chemically synthesised medicines based on its proprietary bicyclic peptide (Bicycle®) product platform to address therapeutic needs unreachable with existing treatment modalities. Bicycle’s internal focus is in oncology, where the company is developing targeted cytotoxics (Bicycle Toxin Conjugates®), targeted innate immune activators and T-cell modulators for cancers of high unmet medical need. Bicycles’ small size and exquisite targeting deliver rapid tumour penetration and retention while clearance rates and routes of elimination can be tuned to minimise exposure of healthy tissue and bystander toxicities. The company’s lead program, BT1718, is being evaluated in a Phase I/IIa trial in collaboration with Cancer Research UK. The company’s unique intellectual property is based on the work initiated at the MRC Laboratory of Molecular Biology in Cambridge, U.K., by the scientific founders of the company, Sir Gregory Winter, a winner of the Nobel Prize in Chemistry for his pioneering work in phage display of peptides and antibodies, and Professor Christian Heinis. Bicycle has its headquarters in Cambridge, U.K., with many key functions and members of its leadership team located in the biotech hub of Boston, Mass. For more information, visit www.bicycletherapeutics.com or follow us on Twitter at @Bicycle_tx.

Press Information


Published by
Hossam Abdel-Kader
+43 1 9582319
e-mail
http://www.pr-inside.com/


# 420 Words
Related Articles
More From The Author
Textio European Customer Base Grows More Than [..]
Textio : “Co-op started using Textio last year, and the platform gave us consistent, objective guidance that we had been [..]
Influbook announces their ICO
Connecting influencers, businesses, and consumers for a new social-commerce experience. Influbook, the first open-network for [..]
European DataWarehouse Announces UK Subsidiary
European DataWarehouse (ED) today announced it has established a UK Subsidiary, European DataWarehouse Ltd. The new subsidiary enforces [..]
Saniona signs option agreement with Initiator Pharma
PRESS RELEASE November 8, 2018 Saniona, a leading biotech company within ion-channel research, today announced that it has entered [..]
4D pharma plc Announces Clinical Update for [..]
First Patient Enrolment in Blautix IBS Phase II Study LEEDS, United Kingdom, Nov. 08, 2018 (GLOBE NEWSWIRE) -- 4D pharma [..]
 
More From Business
3,300+ Finance, Business Leaders Join Asian Financial [..]
HONG KONG, Jan 16, 2019 - (ACN Newswire) - More than 3,300 financial policymakers, financial elites and business leaders attended [..]
The Executive Talk: Chememan PCL (SET:CMAN)
BANGKOK, Jan 15, 2019 - (ACN Newswire) - Chememan PCL (SET:CMAN) Chief Executive Officer, Mr. Adisak Lowjun discusses the company's [..]
Sapphire's Subsidiary Awarded EPC Contract of RMB [..]
SINGAPORE, Jan 15, 2019 - (ACN Newswire) - SGX Mainboard-listed Sapphire Corporation Limited ("Sapphire", and together [..]
Hong Kong Investment Promotion chief visits London [..]
HONG KONG, Jan 14, 2019 - (ACN Newswire) - The Director-General of Investment Promotion of the Hong Kong Special Administrative [..]
Wildfire Design & Build Receives 2018 Best [..]
NAPA December 13, 2018 -- Wildfire Design & Build has been selected for the 2018 Best of Napa Award in [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.